Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05519592
Other study ID # 2022-A01457-36
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date September 9, 2022
Est. completion date October 30, 2023

Study information

Verified date August 2022
Source Henri Mondor University Hospital
Contact etienne savard
Phone 0033149813299
Email etienne.savard@aphp.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To assess feasability, tolerance of anesthesic intramuscular motor block. To study immediate effects on differents muscles : gluteus maximus, rectus femoris in a hemiparetic population (over 15 days) To precise the role of the muscles which could be rehabilitatoin targets.


Description:

Spastic paresis comprises both muscular and neurological disorders affecting movement through mostly the antagonist muscles compared to the agonist : muscular : spastic myopathy, shortening, stretch-sensitive paresis and neurogenic : spastic dystonia and cocontraction. About gait, most of the litterature focuses on distal muscles targets. There are no studies about proxmial muscles role (gluteus maximus). Anesthesic perineural block have the disavantage to induce sensitive block as intramuscular block do not.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date October 30, 2023
Est. primary completion date May 2, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - able to consent - avoiding ground swing phase gait disorder Exclusion Criteria: - severe cognitive disorder - INR > 3.5 - local cutaneous affection on injection sites - acute medical affection - seizure - hypersensitivity to anesthesics - brugada syndrome - porphyria - severe cardiac disorder - polyradiculopathy - botulinum toxin injection < 2 months

Study Design


Intervention

Drug:
Ropivacaine injection
Intramuscular ropivacaine injection (gluteus maximus and rectus femoris)
Sodium Chloride Injection
Intramuscular sodium chloride injection (gluteus maximus and rectus femoris)

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Henri Mondor University Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline of the active amplitude of hip flexion, knee flexion and ankle flexion baseline, day 7 and day 14
Secondary change from baseline of the walking speed, at maximal speed, with shoes baseline, day 7 and day 14
Secondary change from baseline of the walking speed, at maximal speed, without shoes baseline, day 7 and day 14
Secondary change from baseline of the walking speed, at comfortable speed with shoes baseline, day 7 and day 14
Secondary change from baseline of the walking speed, at comfortable speed without shoes baseline, day 7 and day 14
Secondary change from baseline of the right step length, at maximal speed, with shoes baseline, day 7 and day 14
Secondary change from baseline of the left step length, at maximal speed, with shoes baseline, day 7 and day 14
Secondary change from baseline of the left step length, at maximal speed, without shoes baseline, day 7 and day 14
Secondary change from baseline of the right step length, at maximal speed, without shoes baseline, day 7 and day 14
Secondary change from baseline of the right step length, at comfortable speed, without shoes baseline, day 7 and day 14
Secondary change from baseline of the right step length, at comfortable speed, with shoes baseline, day 7 and day 14
Secondary change from baseline of the left step length, at comfortable speed, with shoes baseline, day 7 and day 14
Secondary change from baseline of the left step length, at comfortable speed, without shoes baseline, day 7 and day 14
Secondary change from baseline of the cadence (step per second), at comfortable speed, without shoes baseline, day 7 and day 14
Secondary change from baseline of the cadence (step per second), at comfortable speed, with shoes baseline, day 7 and day 14
Secondary change from baseline of the cadence (step per second), at maximal speed, with shoes baseline, day 7 and day 14
Secondary change from baseline of the cadence (step per second), at maximal speed, without shoes baseline, day 7 and day 14
Secondary change from baseline of Proprioception detection of gluteus maximus (minimal detectable change in degrees) using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of Proprioception detection of hamstrings (minimal detectable change in degrees) using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of Proprioception detection of vastus (minimal detectable change in degrees) using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of Proprioception detection of rectus femoris (minimal detectable change in degrees) using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of Proprioception detection of soleus (minimal detectable change in degrees) using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of Proprioception detection of gastrocnemius (minimal detectable change in degrees) using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of Passive range of motion of gluteus maximus (muscle length in degrees) using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of Passive range of motion of rectus femoris (muscle length in degrees) using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of Passive range of motion of vastus (muscle length in degrees) using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of Passive range of motion of soleus (muscle length in degrees) using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of Passive range of motion of gastrocnemius (muscle length in degrees) using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of Passive range of motion of hamstrings (muscle length in degrees) using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of spasticity (angle in degrees) of hamstrings using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of spasticity (angle in degrees) of gluteus maximus using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of spasticity (angle in degrees) of rectus femoris using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of spasticity (angle in degrees) of vastus using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of spasticity (angle in degrees) of soleus using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of spasticity (angle in degrees) of gastrocnemius using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of active amplitude against gastrocnemius baseline, day 7 and day 14
Secondary change from baseline of active amplitude against soleus baseline, day 7 and day 14
Secondary change from baseline of active amplitude against hamstrings baseline, day 7 and day 14
Secondary change from baseline of active amplitude against gluteus maximus baseline, day 7 and day 14
Secondary change from baseline of active amplitude against rectus femoris baseline, day 7 and day 14
Secondary change from baseline of active amplitude against vastus baseline, day 7 and day 14
Secondary change from baseline of fatigability against vastus (in degrees, after 15 second of alternative movement) using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of fatigability against rectus femoris (in degrees, after 15 second of alternative movement) using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of fatigability against gluteus maximus (in degrees, after 15 second of alternative movement) using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of fatigability against hamstrings (in degrees, after 15 second of alternative movement) using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of fatigability against gastrocnemius (in degrees, after 15 second of alternative movement) using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of fatigability against soleus (in degrees, after 15 second of alternative movement) using the five steps assessment (Gracies JM) baseline, day 7 and day 14
Secondary change from baseline of patient global impression of improvement GPI-I questionnaire baseline, day 7 and day 14
Secondary change from baseline of right foot pressure distribution baseline, day 7 and day 14
Secondary change from baseline of left foot pressure distribution baseline, day 7 and day 14
Secondary change from baseline of left foot load baseline, day 7 and day 14
Secondary change from baseline of right foot load baseline, day 7 and day 14
Secondary change from baseline of stride velocity variability baseline, day 7 and day 14
Secondary change from baseline of stride length variability baseline, day 7 and day 14
Secondary change from baseline of stride time variability baseline, day 7 and day 14
Secondary change from baseline of stance time variability baseline, day 7 and day 14
Secondary change from baseline of double support time variability baseline, day 7 and day 14
Secondary change from baseline of swing time assymetry baseline, day 7 and day 14
Secondary change from baseline of stride time assymetry baseline, day 7 and day 14
Secondary change from baseline of stride time baseline, day 7 and day 14
Secondary change from baseline of swing time baseline, day 7 and day 14
Secondary change from baseline of stance time baseline, day 7 and day 14
Secondary change from baseline of stride velocity baseline, day 7 and day 14
See also
  Status Clinical Trial Phase
Recruiting NCT04098679 - Childhood Adiposity and Neurodevelopmental Outcomes Among Offspring of Women With Type 1 Diabetes (CONCEPTT Kids)
Recruiting NCT06146543 - Stress Ball During Lumbar Puncture the Effect of the Application on Anxiety Level N/A
Completed NCT03946137 - Chest Therapy and Postural Education in Children With Cerebral Palsy N/A
Completed NCT05217186 - Associations Between Early Neonatal Neuroimaging, Hammersmith Infant Neurological Examination and General Movements
Not yet recruiting NCT05506306 - Multitissular Effect of Vertical Mobilization Using the Exoskeleton AtalanteTM in Neurological Chair- or Bed-bound Patients
Recruiting NCT05260190 - Manual Dexterity Modifications After Application of tSMS Over the Primary Motor Cortex (M1) N/A
Recruiting NCT04846413 - Voice Analysis in Patients With Neurologic Diseases
Not yet recruiting NCT04906681 - Implementation of a Rehabilitation Technology in Orthopedic and Neurological Rehabilitation to Increase Therapy Dosage: an Exploratory Study Phase 1/Phase 2
Completed NCT04743037 - Interactive Self-Management Augmented by Rehabilitation Technologies N/A
Not yet recruiting NCT03899298 - Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions Phase 1
Active, not recruiting NCT04631965 - Healthcare Transition of Adolescents With Chronic Health Conditions
Recruiting NCT05132517 - Magnesium and Cognition After Stroke
Recruiting NCT04100993 - Multisystem and Autonomic Complications of NMD on Long-term NIV
Recruiting NCT05652946 - IISART (International Industry Society of Advanced Rehabilitation Technology) Advanced Rehabilitation Technology Study N/A
Completed NCT06368024 - Establishment of Delphi-MD Safety Performance and Reliability
Not yet recruiting NCT06169696 - EMPOWER Early Feasibility Study: Non-invasive BCI to Control a Wheelchair for People With Paralysis N/A
Completed NCT03329872 - Neuro-Orthopedic Registry of the University Hospital of Toulouse
Completed NCT05483244 - Weaning Success in Different Weaning Strategies in Early Neurological Rehabilitation Patients - a Matched-pair Analysis
Active, not recruiting NCT04170985 - NeuroSeq: A Prospective Trial to Evaluate the Diagnostic Yield of Whole Genome Sequencing (WGS) in Adult Neurology N/A
Completed NCT04624347 - NEOVIDEO : Impact of Monitoring Motor Activity by Video Analysis on the Sleep of Very Preterm Infants N/A